- Home
- SISI vs INM Comparison
SISI vs INM Comparison
Compare SISI & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SISI
- INM
- Stock Information
- Founded
- SISI 1997
- INM 1981
- Country
- SISI China
- INM Canada
- Employees
- SISI N/A
- INM N/A
- Industry
- SISI Medicinal Chemicals and Botanical Products
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- SISI Health Care
- INM Health Care
- Exchange
- SISI Nasdaq
- INM Nasdaq
- Market Cap
- SISI 4.0M
- INM 3.2M
- IPO Year
- SISI 2016
- INM N/A
- Fundamental
- Price
- SISI $0.17
- INM $2.66
- Analyst Decision
- SISI
- INM
- Analyst Count
- SISI 0
- INM 0
- Target Price
- SISI N/A
- INM N/A
- AVG Volume (30 Days)
- SISI 3.1M
- INM 5.8M
- Earning Date
- SISI 05-15-2025
- INM 05-12-2025
- Dividend Yield
- SISI N/A
- INM N/A
- EPS Growth
- SISI N/A
- INM N/A
- EPS
- SISI N/A
- INM N/A
- Revenue
- SISI $9,601,324.00
- INM $4,920,990.00
- Revenue This Year
- SISI N/A
- INM N/A
- Revenue Next Year
- SISI N/A
- INM N/A
- P/E Ratio
- SISI N/A
- INM N/A
- Revenue Growth
- SISI 1133.26
- INM N/A
- 52 Week Low
- SISI $0.15
- INM $1.72
- 52 Week High
- SISI $27.60
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- SISI 29.18
- INM 45.77
- Support Level
- SISI $0.16
- INM $2.69
- Resistance Level
- SISI $0.18
- INM $3.28
- Average True Range (ATR)
- SISI 0.02
- INM 0.20
- MACD
- SISI 0.01
- INM -0.05
- Stochastic Oscillator
- SISI 19.22
- INM 9.81
About SISI Shineco Inc.
Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed various vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.